Skip to main content

Table 4 Immunocytochemical scores for MMP-9, MMP-2 and VEGF-A in B-cell lymphomas, T-cell lymphomas and control lymph nodes expressed as mean (min-max)

From: The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study

  MMP-9 MMP-2 VEGF-A
HG B-cell lymphomas 22.1% (13–35) 16.9% (3–22) 17.3% (11–23)
LG B-cell lymphomas 15.7% (11–27) 4.2% (2–7) 13.8% (12–17)
HG T-cell lymphomas 79.8% (56–89) 38.4% (29–45) 44.7% (38–48)
LG T-cell lymphomas 41.3% (25–63) 30.2 (26–33) 30.2% (18–37)
Control lymph nodes 4.2% (1–7) 0.8% (0–2) 0.8% (0–2)